Clinical trial

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

NCT05726916

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-11-09

PhasePHASE3

Study timeline

Study start (actual)2023-11-09Date precision: day

Registry last updated2024-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensive Emergency-associated Hemolytic Uremic Syndromeunresolved

Interventions

Soliris®DRUG

Renin angiotensin system blockersDRUG

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05726916 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.